<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The forkhead box transcription factor FOXQ1 has been shown to be upregulated in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) and metastatic <z:hpo ids='HP_0003002'>breast cancer</z:hpo> and involved in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development, epithelial-mesenchymal transition and chemoresistance </plain></SENT>
<SENT sid="1" pm="."><plain>Yet, its transcriptional regulation is still unknown </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: FOXQ1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein expression were analysed in a panel of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines, and laser micro-dissected human biopsy samples by qRT-PCR, microarray GeneChipÂ® U133 Plus 2.0 and western blots </plain></SENT>
<SENT sid="3" pm="."><plain>FOXQ1 regulation was assayed by chromatin immunoprecipitation and luciferase reporter assays </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: FOXQ1 was robustly induced in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> compared to other <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, but had no predictive value with regards to grade, <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and survival in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Prototype-based gene coexpression and gene set enrichment analysis showed a significant association between FOXQ1 and the Wnt pathway in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell lines from different tissues </plain></SENT>
<SENT sid="6" pm="."><plain>In vitro experiments confirmed, on a molecular level, FOXQ1 as a direct Wnt target </plain></SENT>
<SENT sid="7" pm="."><plain>Analysis of known Wnt targets identified FOXQ1 as the most suitable marker for canonical Wnt activation across a wide panel of cell lines derived from different tissues </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Our data show that FOXQ1 is one of the most over-expressed genes in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and a direct target of the canonical Wnt pathway </plain></SENT>
<SENT sid="9" pm="."><plain>It is a potential new marker for detection of early <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and Wnt activation in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> of different origins </plain></SENT>
</text></document>